Much of the research on new cancer treatments in the last two decades has focused on genetic targets that allow cancers to grow and spread by altering cell signaling or shutting off tumor suppressors. There is a growing body ...
Apr 7, 2023
0
64
A new editorial perspective titled "Cancer-associated fibroblasts: challenges and opportunities" has been published in Oncotarget.
Apr 5, 2023
0
0
Two key proteins linked to cell division can reliably predict disease recurrence in prostate cancer after radiotherapy treatment, according to new research.
Apr 4, 2023
0
37
Cancer is no longer incurable. Nevertheless, according to data released by Statistics Korea last year, cancer remained the primary cause of mortality in Korea in 2021. This highlights the ongoing struggle against cancer, ...
Apr 4, 2023
0
21
A study recently published in the journal Science China Life Sciences was led by Professor Qimin Zhan (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, ...
Apr 3, 2023
0
2
Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated ...
Apr 1, 2023
0
30
Research from Johns Hopkins Kimmel Cancer Center experts revealed a type of RNA, previously considered to be "junk," that may help doctors distinguish and treat a subgroup of patients with medulloblastoma.
Mar 23, 2023
0
27
Cancer treatments have long been moving toward personalization—finding the right drugs that work for a patient's unique tumor, based on specific genetic and molecular patterns. Many of these targeted therapies are highly ...
Mar 17, 2023
0
60
A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of multiple types of blood cancers but has shown limited efficacy against glioblastoma—the deadliest type of ...
Mar 13, 2023
0
65
Introducing bacteria to a tumor's microenvironment creates a state of acute inflammation that triggers the immune system's primary responder cells to attack rather than protect a tumor, according to a new study from the Garvan ...
Mar 13, 2023
0
101
